EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers

Claudio Sorino iD, Michele Mondoni iD, Giampietro Marchetti, Sergio Agati, Riccardo Inchingolo iD, Federico Mei iD, Sara Flamini, Filippo Lococo iD, David Feller-Kopman iD

Journal of Clinical Medicine · 09.11.2023 · 12 (22) · 7006

DOI: 10.3390/jcm12227006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.11.2023. Verfasst von Claudio Sorino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonology, Sant'Anna Hospital of Como, University of Insubria, 21100 Varese, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pleural mesothelioma (PM) is a type of cancer that is highly related to exposure to asbestos fibers. It shows aggressive behavior, and the current therapeutic approaches are usually insufficient to change the poor prognosis. Moreover, apart from staging and histological classification, there are no validated predictors of its response to treatment or its long-term outcomes. Numerous studies have investigated minimally invasive biomarkers in pleural fluid or blood to aid in earlier diagnosis and prognostic assessment of PM. The most studied marker in pleural effusion is mesothelin, which exhibits good specificity but low sensitivity, especially for non-epithelioid PM. Other biomarkers found in pleural fluid include fibulin-3, hyaluronan, microRNAs, and CYFRA-21.1, which have lower diagnostic capabilities but provide prognostic information and have potential roles as therapeutic targets. Serum is the most investigated matrix for biomarkers of PM. Several serum biomarkers in PM have been studied, with mesothelin, osteopontin, and fibulin-3 being the most often tested. A soluble mesothelin-related peptide (SMRP) is the only FDA-approved biomarker in patients with suspected mesothelioma. With different serum and pleural fluid cut-offs, it provides useful information on the diagnosis, prognosis, follow-up, and response to therapy in epithelioid PM. Panels combining different markers and proteomics technologies show promise in terms of improving clinical performance in the diagnosis and monitoring of mesothelioma patients. However, there is still no evidence that early detection can improve the treatment outcomes of PM patients.

Schlagwörter

Stichwörter der Autor:innen

biomarkersfibulin-3mesothelinmesotheliomapleural effusion

Autor:innen und Institutionen

  • Division of Pulmonology, Sant'Anna Hospital of Como, University of Insubria, 21100 Varese, Italy.
  • Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, 20122 Milan, Italy.
  • Pulmonology Unit, ASST Spedali Civili, 25123 Brescia, Italy.
  • Pulmonary Medicine Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Respiratory Diseases Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.
  • Departement of Thoracic Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

ORCID-Profile: Claudio Sorino, Michele Mondoni, Riccardo Inchingolo, Federico Mei, Filippo Lococo, David Feller-Kopman

Förderung

  • University of Milan

Zitieren

APA

Sorino, C., Mondoni, M., Marchetti, G., Agati, S., Inchingolo, R., Mei, F., Flamini, S., Lococo, F., & Feller-Kopman, D. (2023). Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers. Journal of Clinical Medicine, 12(22), 7006. https://doi.org/10.3390/jcm12227006

Vancouver

Sorino C, Mondoni M, Marchetti G, Agati S, Inchingolo R, Mei F, et al. Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers. Journal of Clinical Medicine. 2023;12(22):7006. doi:10.3390/jcm12227006

BibTeX
@article{Sorino2023,
  author = {Sorino, Claudio and Mondoni, Michele and Marchetti, Giampietro and Agati, Sergio and Inchingolo, Riccardo and Mei, Federico and Flamini, Sara and Lococo, Filippo and Feller-Kopman, David},
  title = {Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {22},
  pages = {7006},
  doi = {10.3390/jcm12227006}
}
Kostenlos starten →